Pharmacogenetics of irinotecan: A promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan

By Ando Maki   Hasegawa Yoshinori   Ando Yuichi  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 539-545

Springer Publishing Company

Access to resources Recommend Favorite

Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism

By Font Albert   Sánchez José Miguel   Tarón Miquel   Martinez-Balibrea Eva   Sánchez José Javier   Manzano José Luis   Margelí Mireia   Richardet Martin   Barnadas Agustí   Abad Albert   Rosell Rafael  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 435-443

Springer Publishing Company

Access to resources Recommend Favorite

Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysis

By Dias Mafalda M   McKinnon Ross A   Sorich Michael J  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 889-899

Future Medicine

Access to resources Recommend Favorite

Update on tools for evaluation of uridine diphosphoglucuronosyltransferase polymorphisms

By Argikar Upendra A   Iwuchukwu Otito F   Nagar Swati  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 879-894

Informa Healthcare

Access to resources Recommend Favorite

ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 23-30

Bentham Science Publishers

Access to resources Recommend Favorite